Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — Food and Drug Administration & American Cancer Society

7 shared events · Importance 4 · Last updated Aug 27, 2026

Importance
4
Shared Events
7
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
49
Regulatory
United States — Food and Drug Administration: The FDA approved SimpleScreen CRC, adding a new blood-based screening option for colorectal cancer.
American Cancer Society: The American Cancer Society is expected to include SimpleScreen CRC in its screening guidelines by name.
Jul 27, 2026 · 6 articles
42
Tech
United States — Food and Drug Administration: Granted expedited approval of daraxonrasib more than six months ahead of its target date, reinforcing its accelerated-review posture for serious diseases.
American Cancer Society: Provided epidemiology cited across coverage, underscoring the large patient population and high mortality that define the drug's market opportunity.
Aug 26, 2026 · 6 articles
40
Tech
United States — Food and Drug Administration: The United States — Food and Drug Administration is expediting the review of daraxonrasib and has allowed expanded access to the drug, indicating its critical role in bringing this new treatment to patients.
American Cancer Society: The American Cancer Society provides statistics on pancreatic cancer, highlighting the severity of the disease and the need for new treatments like daraxonrasib.
May 29, 2026 · 74 articles
40
Tech
United States — Food and Drug Administration: The FDA is the regulatory authority that must approve the vaccine. Approval could come as soon as 2027, but the agency's review process and potential political interference from the administration could affect the timeline.
American Cancer Society: The American Cancer Society provided statistics on melanoma incidence and mortality, highlighting the disease burden that the vaccine aims to address. It is not directly financially impacted.
Aug 19, 2026 · 126 articles
32
Regulatory
United States — Food and Drug Administration: The FDA granted expedited approval to daraxonrasib, marking a regulatory milestone and demonstrating its commitment to accelerating cancer treatments. The approval was issued 6.5 months ahead of schedule, reflecting the agency's priority review process.
American Cancer Society: The organization provided statistics on pancreatic cancer incidence and mortality, contextualizing the disease burden.
Aug 26, 2026 · 92 articles
30
Regulatory
United States — Food and Drug Administration: Its advisory panel endorsed the test, but the agency still must make the final approval decision and has flagged efficacy concerns.
American Cancer Society: Cited as noting no multi-cancer early detection test has yet been FDA approved.
Sep 23, 2026 · 18 articles
14
Tech
United States — Food and Drug Administration: Mentioned for caffeine intake recommendations, not directly involved.
American Cancer Society: The American Cancer Society provides statistics on liver cancer, highlighting the public health relevance of the study's findings.
Jun 30, 2026 · 21 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — Food and Drug Administration and American Cancer Society interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.